In the tight-skin murine model of SSc, loss of CD19, which is also expressed by plasma cells, led to reduced autoantibody production and skin fibrosis, suggesting that CD19 signaling promotes chronic B cell activation and differentiation into autoantibody producing cells that enhance collagen deposition [43]. The gene discussed is CD19; the disease is systemic sclerosis.